CardiologyVideo course2026
Cleveland Clinic Heart Failure Summit 2026 — amyloid, shock, AI and the newest trials
The Cleveland Clinic Heart Failure Summit 2026 was held on 12–13 June 2026 at the InterContinental Hotel & Conference Center in Cleveland, and this recording gives you all 41 sessions — nearly 11 hours 45 minutes of video with subtitles. Faculty from the Cleveland Clinic Heart, Vascular and Thoracic Institute cover the latest trials (SUMMIT, FINEARTS-HF, VICTOR), cardiac amyloidosis, cardiogenic shock and ECMO, LVAD and transplant allocation, cardio-kidney-metabolic care, gene therapy and practical AI.
- 41sessions
- 11 h 45 minof video
- Jun 2026recorded
What you’ll be able to do
- Put SUMMIT, FINEARTS-HF, RE-DEFINE-HF and VICTOR into everyday HFpEF and HFrEF care
- Match TTR therapy to phenotype and work through AL amyloid decisions
- Pick the right temporary MCS device and ECMO configuration in shock
- Recognise advanced HFrEF early and refer for LVAD or transplant on time
- Build a CKM care model and population-health approach for your service
- Use AI tools for risk prediction without disrupting workflow
Inside the course
Amyloidosis from diagnosis to gene editing
Seven sessions build a complete amyloid pathway: nuclear imaging best practice, matching TTR therapy to phenotype, gene-editing approaches, case-based AL decisions, the musculoskeletal manifestations and how to counsel a patient after a new diagnosis — plus an expert Q&A.
Shock, support and the advanced HF team
Cardiogenic shock from guidelines to bedside, choosing temporary MCS devices, ECMO cannulation from VA to LAVA, personalising LVAD care, continuous-distribution heart allocation, and who can still undergo CABG or valve surgery.
Cleveland Clinic Heart Failure Summit 2026 therapeutics and trials
Tirzepatide in obese HFpEF, finerenone data, digitalis and vericiguat in HFrEF, HFrEF in the device era, metabolic health as a target, diet and exercise, neuregulin and regenerative pathways, and a panel ranking the five most practice-changing trials.
Precision medicine, AI and care at scale
Gene therapy for cardiomyopathy, a CD36 variant as a cause of disease, cardiac sarcoidosis and cardio-oncology in the advanced HF clinic, ambulatory PA monitoring, AF ablation and TAVR in HFrEF, AI decision tools, and population-health networks for equitable care.
Built for
- Cardiologists and HF specialistsA single update on every major heart failure development of the past year.
- Advanced HF and transplant teamsShock, MCS, LVAD and allocation sessions from a leading transplant centre.
- Internists, intensivists and APPsPractical guidance on GDMT, CKM care and when to refer.
- Pharmacists and nursesClear coverage of new drugs, trial results and patient education.
Syllabus
Sessions and running times 41 sessions
- Cardiac Amyloidosis: Expert Q&A on Diagnosis and Management — 10:41
- ECMO Cannulation Strategy: Choosing VA, VAV, LAVA, and Other Configurations — 18:53
- Heart Failure: Navigating Complex Clinical Intersections – Panel Discussion — 09:36
- Cardiac Amyloidosis: Best Practices in Nuclear Imaging and Future Directions — 15:02
- Evolutions in TTR Therapies: Matching Therapy to Phenotype — 18:37
- Transthyretin Amyloidosis: Gene Editing Approaches — 12:29
- AL Amyloidosis: Navigating Complex Diagnostic and Treatment Decisions (Case Based) — 16:18
- Cardiac Amyloidosis: Educating Patients After a New Diagnosis — 18:23
- Amyloidosis and the Musculoskeletal System — 21:15
- Personalizing Care for LVAD Recipients — 15:36
- Heart Allocation by Continuous Distribution: Are We Nearly There Yet? — 15:14
- Cardiogenic Shock: Advanced Therapies – Panel Discussion — 09:50
- Heart Failure: Practical AI Tools for Clinical Decision-Making — 40:18
- Heart Failure: Which Patients Can Undergo CABG and Valve Surgery? — 17:13
- Cardiogenic Shock: From Guidelines to Bedside — 15:45
- Temporary MCS Devices: Right Device, Right Patient, Right Time — 17:05
- HFpEF and Obesity: Tirzepatide Findings From the SUMMIT Trial and Substudies — 14:54
- HFpEF: Clinical Insights From FINEARTS-HF, RE-DEFINE-HF, and Substudies — 12:32
- Neuregulin and Other Regenerative Pathways in HFrEF — 15:29
- Heart Failure: Top Five Practice-Changing Clinical Trials – Panel Discussion — 21:08
- Heart Failure and CKM: Advancing Equitable Care — 21:55
- HF Population Health: From Individual Care to Care Networks — 19:12
- Reframing HF: Treating and Preventing the Syndrome, Its Causes, and Comorbid Conditions — 31:39
- Heart Failure Care at Scale: Population Health Strategies – Panel Discussion — 11:48
- The Role of Digitalis in HFrEF Therapeutics — 16:03
- Vericiguat for HFrEF: Results From the VICTOR Trial — 10:54
- HFrEF in the Device Era — 15:39
- AI in HF: From Risk Prediction to Workflow Integration — 19:48
- Gene Therapy for Cardiomyopathies: Why, Who, and How — 15:13
- Implications of a CD36 Genetic Variant as a Cause of Cardiomyopathy — 16:17
- Metabolic Health as a Therapeutic Target for HFrEF — 18:02
- HF: Expert Q&A on AI, Emerging Therapies, and Future Directions — 18:34
- Ambulatory PA Monitoring: Who, When, How? — 14:34
- When GDMT Isn’t Enough: Recognizing Advanced HFrEF — 17:32
- Heart Failure and Metabolic Disease: Expert Q&A — 17:03
- CKM (Cardio-Kidney-Metabolic) Care Models: Practical Implementation — 18:34
- HFpEF: Integrating Diet and Exercise Into Treatment — 19:07
- Cardiac Sarcoidosis Across the EF Spectrum — 17:31
- Cardio-Oncology in the Advanced HF Clinic — 16:15
- Structural Heart Disease: Which Patients with AS and HFrEF Benefit Most from TAVR? — 16:36
- Atrial Fibrillation in Heart Failure: Advances in Catheter Ablation and Arrhythmia Management — 16:57
Before you buy
Are slides included?
No — this recording is video with subtitles only; there are no PDF handouts.
How long is the course?
The 41 sessions total about 11 hours 45 minutes, from 10-minute panels to a 40-minute AI workshop.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Video with subtitles (no PDFs) |
|---|---|
| Contents | 41 sessions · about 11 h 45 min |
| Recorded | 12–13 June 2026, Cleveland, Ohio |
| Publisher | Cleveland Clinic |
| Department | Cardiology |
| Delivery | Instant download · lifetime re-download |
Related products
Cardiology